Current role
Gwenn M. Hansen
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nurix Therapeutics, Inc. (NRIX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $556,000 | $2,498,124 |
| 2024 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $510,533 | $2,033,860 |
| 2023 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $493,200 | $1,632,757 |
| 2022 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $476,250 | $3,824,583 |
| 2021 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $433,750 | $2,303,328 |
| 2020 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $391,250 | $1,552,577 |
| 2019 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $299,167 | $695,404 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.